Chronic phenytoin therapy causes resistance to some nondepolarising muscle relaxants. We have confirmed that this resistance is seen with vecuronium and suggest that at least a week of phenytoin therapy is required for a significant effect to develop. The mechanism of this resistance is not known. We have shown that an exaggerated rise in serum potassium after succinylcholine does not occur in patients with demonstrated resistance to vecuronium from chronic phenytoin therapy. This would suggest that significant extrajunctional acetylcholine receptor proliferation is an unlikely mechanism.
OrnsteinE., MatteoR.S., SchwartzA.E., SilverbergP.A., YoungW.L., DiazJ.The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.Anesthesiology1987; 67: 191–196.
7.
MartynJ.A.J., SzyfelbeinS.K., AliH.H., MatteoR.S., SavereseJ.J.Increased d-tubocurarine requirement following major thermal injury.Anesthesiology1980; 52: 352–355.
8.
MartynJ.A.J., GoudsouzianN.G., MatteoR.S., LiuL.M.P., SzyfelbeinS.K., KaplanR.F.Metocurine requirements and plasma concentrations in burned patients.Br J Anaesth1983; 55: 265–268.
9.
DwerstegJ.F., PavlinE.G., HeimbachD.M.Patients with burns are resistant to atracurium.Anesthesiology1986; 65: 517–520.
10.
MoorthyS.S., HilgenbergJ.C.Resistance to non-depolarizing muscle relaxants in paretic upper extremities of patients with residual hemiplegia.Anesth Analg1980; 59: 624–627.
11.
ShayevitzJ.R., MatteoR.S.Decreased sensitivity to metocurine in patients with upper motoneuron disease.Anesth Analg1985; 64: 767–772.
12.
HogueC.W., MartynJ.A.J.Lower motor injury induces resistance to d-tubocurarine.Anesthesiology1988; 69: A501.
13.
BrettR.S., SchmidtJ.H., GageJ.S., SchartelS.A., PoppersP.J.Measurement of acetylcholine receptor concentration in skeletal muscle from a patient with multiple sclerosis and resistance to atracurium.Anesthesiology1987; 66: 837–839.
14.
MoorthyS.S., KrishnaG., DierdorfS.F.Resistance to vecuronium in patients with cerebral palsy.Anesth Analg1991; 73: 275–277.
15.
GronertG.A.Disuse atrophy with resistance to pancuronium.Anesthesiology1981; 55: 547–549.
16.
WaudB.E., WaudD.R.Tubocurarine sensitivity of the diaphragm after limb immobilization.Anesth Analg1986; 65: 493–495.
17.
MatteoR.S., DiazJ.Resistance to d-tubocurarine in cats following 72 hours of continuous paralysis.Anesthesiology1984; 61: A310.
18.
CoursinD.B., KlasekG., GoelzerS.L.Increased requirements for continuously infused vecuronium in critically ill patients.Anesth Analg1989; 69: 518–521.
19.
ParrS.M., GalletlyD.C., RobinsonB.J.Betamethasone-induced resistance to vecuronium: a potential problem in neurosurgery?Anaesth Intens Care1991; 19: 103–105.
20.
AzarI., KumarD., BetcherA.M.Resistance to pancuronium in an asthmatic patient treated with aminophylline and steroids.Can Anaesth Soc J1982; 29: 280–282.
FambroughD.M.Control of acetylcholine receptors in skeletal muscle.Physiol Rev1979; 59: 165–227.
23.
KimC., FukeN., MartynJ.A.J.Burn injury to rat increases nicotinic acetylcholine receptors in the diaphragm.Anesthesiology1988; 68: 401–406.
24.
HogueC.W., ItaniM.S., MartynJ.A.J.Resistance to d-tubocurarine in lower motor neuron injury is related to an increase in acetylcholine receptors.Anesthesiology1989; 71: A1203.
25.
HogueC.W., ItaniM.S., MartynJ.A.J.Continuous infusion of d-tubocurarine induces tolerance and increases in nicotinic acetylcholine receptors.Anesthesiology1990; 73: A1273.
26.
GandhiI.C., JindalM.N., PatelV.K.Mechanism of neuromuscular blockade with some antiepileptic drugs.Arzneimittelforschung1976; 26: 258–261.
27.
RainesA., StandaertF.G.Pre- and postjunctional effects of diphenylhydantoin at the cat soleus neuromuscular junction.J Pharmacol Exp Ther1966; 153: 361–366.
28.
YaaiY., PincusJ.H., ArgovZ.Depression of synaptic transmission by diphenylhydantoin,Ann Neurol1977; 1: 334–338.
29.
YentisS.M.Suxamethonium and hyperkalaemia.Anaesth Intens Care1990; 18: 92–101.
30.
GronertG.A., TheyeR.A.Pathophysiology of hyperkalaemia induced by succinylcholine.Anesthesiology1975; 43: 89–99.
31.
McCarthyG., PanditS.K., McLoughlinC., MirakhurR.K., ClarkeR.S.J.A study of vecuronium propofol interaction.Anesthesiology1990; 73: A899.
32.
JacqueJ.J., GoldMl, deLisserE.A.Is propofol a muscle relaxant?Anesth Analg1990; 70: S172.
33.
SohnY.J., BenciniA., ScafA.H.J., KerstenU.W., GregorettiS., AgostonS.Pharmacokinetics of vecuronium in man.Anesthesiology1982; 57: A256.
34.
CronnelyR., FisherD.M., MillerR.D., GencarelliP., Nguyen-GruenkeL., CastagnoliN.Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) and pancuronium in anesthetized humans.Anesthesiology1982; 58: 405–408.
35.
ShanksC.A., AvramM.J., FragenR.J., O'HaraD.A.Pharmacokinetics and pharmacodynamics of vecuronium administered by bolus and infusion during halothane or balanced anesthesia.Clin Pharmacol Ther1987; 42: 459–64.
36.
GrayHStJ, SlaterR.M., PollardB.J.The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade.Anaesthesia1989; 44: 379–381.
37.
MeretojaO.A., McHutchinsonG., BrownT.C.K.Alcuronium requirements in patients receiving phenytoin—a case report.Anaesth Intens Care1990; 18: 483–485.
38.
ReddyP., GuzmanA., RobalinoJ., ShevdeK.Resistance to muscle relaxants in a patient receiving prolonged testosterone therapy.Anesthesiology1989; 70: 871–873.
39.
EisenkraftJ.B., RothD.M.Effect of steroid therapy on sensitivity to vecuronium: a dose-response study.Anesthesiology1989; 71: A791.
40.
DurantN.N., BriscoeJ.R., KatzR.L.The effects of acute and chronic hydrocortisone treatment on neuromuscular blockade in the anesthetized cat.Anesthesiology1984; 61: 144–150.
41.
MartynJ.A.J., KimC.S.Decreased sensitivity to metocurine during chronic phenytoin may be due to protein binding and receptor changes.Anesthesiology1991; 75: A640.
42.
AliH.H., GoudsouzianM.D.Effect of succinylcholine on plasma potassium, elderly vs young.Anesth Analg1991; 72: S4.
43.
FungD.L., WhiteD.A., JoneseB.R., GronertG.A.The onset of disuse-related potassium efflux to succinylcholine.Anesthesiology1991; 75: 650–653.
44.
PatonW.D.M.Mode of action of neuromuscular blocking drugs.Br J Anaesth1956; 28: 470–80.
45.
ListW.F.Serum potassium changes during induction of anaesthesia.Br J Anaesth1967; 39: 480–4.
46.
WeinstraubH.D., HeisterkampD.V., CoopermanL.H.Changes in plasma potassium after depolarising blockers in anaesthetized man.Br J Anaesth1969; 41: 1048–52.
47.
StovnerJ., EndresenR., BjelkeE.Suxamethonium hyperkalaemia with different induction agents.Acta Anaesthesiol Scand1972; 16: 46–50.
48.
BaliI.M., DundeeJ.W.Immediate changes in plasma potassium, sodium and chloride induced by intravenous induction agents.Br J Anaesth1974; 46: 929–933.
49.
FogartyD.J., McCleaneG.J.Propofol and serum potassium.Anaesthesia1992; 47: 63–64.
50.
StevensonP.H., BirchA.A.Succinylcholine-induced hyperkalemia in a patient with a closed head inhury.Anesthesiology1979; 51: 89–90.
51.
IwatsukiN., KurodaN., AmahaK., IwatsukiK.Succinylcholine-induced hyperkalemia in patients with ruptured cerebral aneurysms.Anesthesiology1980; 53: 64–7.
52.
FrankvilleD.D., DrummondJ.C.Hyperkalemia after succinylcholine administration in a patient with closed head injury without paresis.Anesthesiology1987; 67: 264–266.
53.
ShanksC.A.Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens.Anesthesiology1986; 64: 72–86.
54.
FisherD.M., RosenJ.I.A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants.Anesthesiology1986; 65: 286–291.
55.
GinsbergB., GlassP.S., QuillT., ShafronD., OsseyK.D.Onset and duration of neuromuscular blockade following high-dose vecuronium administration.Anesthesiology1989; 71: 201–205.
56.
BenciniA.F., ScafA.H.J., SohnY.J., Kersten-KleefU.W., AgostoneS.Hepatobiliary disposition of vecuronium bromide in man.Br J Anaesth1986; 58: 988–995.
57.
DuvaldestinP., HenzelD.Binding of tubocurarine, fazadinium, pancuronium and ORG NC45 to serum proteins in normal man and in patients with cirrhosis.Br J Anaesth1982; 54: 513–516.